(Q48131663)

English

Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.

scientific article published on 20 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

major depressive disorder

1 reference

based on heuristic

inferred from title

Hans-Jürgen Möller

1

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

8 February 2018

author name string

Koen Demyttenaere

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Bengt Olausson

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Johan Szamosi

4

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Ellis Wilson

5

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

David Hosford

6

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Geoffrey Dunbar

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Raj Tummala

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Hans Eriksson

9

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

publication date

20 January 2015

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

16

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

7

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

483-501

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

A recycling framework for the construction of Bonferroni-based multiple tests.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Potential therapeutic uses of mecamylamine and its stereoisomers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Nicotinic acetylcholine receptors as targets for antidepressants.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Severity classification on the Hamilton Depression Rating Scale

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.989261

21 January 2018

Identifiers

10.3109/15622975.2014.989261

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25602163

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48131663&oldid=1510068450"